Company Earnings Update 4 minutesRegister for Free AccessCVS Health (NYSE: CVS) 2Q19 Results: Narrows Profit and Earnings Outlook on Aetna Strength Coresight Research August 9, 2019 Executive Summary CVS Health reported 2Q19 revenues of $63.4 billion, up 35.2% year over year and ahead of the consensus estimate. Diluted EPS was $1.49, versus a loss per share of $2.52 in 2Q18. CVS closed its acquisition of Aetna in November 2018 and was the primary growth driver during the quarter, along with increased volumes and brand name drug price inflation. For FY19, CVS narrowed its adjusted EPS guidance range to $6.89-7.00 from $6.75-6.90. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: August 2023 China Retail Sales: Growth Rate Improves, Breaking Three-Month Downward TrendRetail Around the World: Singles’ Day 2023—Coresight Research ObservationsThe State of In-Store Retailing: Opportunities To Redefine OperationsCoresight Bites: China Consumer Tracker—Some Positive Trends Despite Overall High Avoidance of Public Places